Top

BMC Cancer

Published in:

Open Access 01-12-2016 | Research article

Randomised controlled trial of a home-based physical activity intervention in breast cancer survivors

Authors: Ian M. Lahart, George S. Metsios, Alan M. Nevill, George D. Kitas, Amtul R. Carmichael

Published in: BMC Cancer | Issue 1/2016

Abstract

Background

To improve adherence to physical activity (PA), behavioural support in the form of behavioural change counselling may be necessary. However, limited evidence of the effectiveness of home-based PA combined with counselling in breast cancer patients exists. The aim of this current randomised controlled trial with a parallel group design was to evaluate the effectiveness of a home-based PA intervention on PA levels, anthropometric measures, health-related quality of life (HRQoL), and blood biomarkers in breast cancer survivors.

Methods

Eighty post-adjuvant therapy invasive breast cancer patients (age = 53.6 ± 9.4 years; height = 161.2 ± 6.8 cm; mass = 68.7 ± 10.5 kg) were randomly allocated to a 6-month home-based PA intervention or usual care. The intervention group received face-to-face and telephone PA counselling aimed at encouraging the achievement of current recommended PA guidelines. All patients were evaluated for our primary outcome, PA (International PA Questionnaire) and secondary outcomes, mass, BMI, body fat %, HRQoL (Functional assessment of Cancer Therapy-Breast), insulin resistance, triglycerides (TG) and total (TC), high-density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C) cholesterol were assessed at baseline and at 6-months.

Results

On the basis of linear mixed-model analyses adjusted for baseline values performed on 40 patients in each group, total, leisure and vigorous PA significantly increased from baseline to post-intervention in the intervention compared to usual care (between-group differences, 578.5 MET-min∙wk⁻¹, p = .024, 382.2 MET-min∙wk⁻¹, p = .010, and 264.1 MET-min∙wk⁻¹, p = .007, respectively). Both body mass and BMI decreased significantly in the intervention compared to usual care (between-group differences, −1.6 kg, p = .040, and −.6 kg/m², p = .020, respectively). Of the HRQoL variables, FACT-Breast, Trial Outcome Index, functional wellbeing, and breast cancer subscale improved significantly in the PA group compared to the usual care group (between-group differences, 5.1, p = .024; 5.6, p = .001; 1.9 p = .025; and 2.8, p = .007, respectively). Finally, TC and LDL-C was significantly reduced in the PA group compared to the usual care group (between-group differences, −.38 mmol∙L⁻¹, p = .001; and −.3 mmol∙L⁻¹, p = .023, respectively).

Conclusions

We found that home-based PA resulted in significant albeit small to moderate improvements in self-reported PA, mass, BMI, breast cancer specific HRQoL, and TC and LDL-C compared with usual care.

ClinicalTrials.gov identifier

NCT02408107 (March 25, 2015)

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA. 2011;61(2):69–90. doi:10.3322/caac.20107.PubMed

Office for National Statistics. Cancer incidence and mortality 2007–09. In: Office for National Statistics Statistical Bulletin. Office for National Statistics. 2012. http://www.ons.gov.uk/ons/dcp171778_259504.pdf. Accessed 17 Feb 2015.

Moller H, Fairley L, Coupland V, Okello C, Green M, Forman D, et al. The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer. 2007;96(9):1484–8. doi:10.1038/sj.bjc.6603746.CrossRefPubMedPubMedCentral

Office for National Statistics. Cancer survival by cancer network in england - patients diagnosed 1996–2009 and followed up to 2010. In: Office for National Statistics Statistical Bulletin. Office for National Statistics. 2011. http://www.ons.gov.uk/ons/dcp171778_247385.pdf. Accessed 17 Feb 2015.

Azim Jr HA, de Azambuja E, Colozza M, Bines J, Piccart MJ. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol. 2011;22(9):1939–47. doi:10.1093/annonc/mdq683.CrossRefPubMed

Bovelli D, Plataniotis G, Roila F, Group EGW. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21 Suppl 5:v277–82. doi:10.1093/annonc/mdq200.CrossRefPubMed

van Dalen EC, Michiels EM, Caron HN, Kremer LC. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev. 2010;5:CD005006. doi:10.1002/14651858.CD005006.pub4.

Demark-Wahnefried W, Morey MC, Clipp EC, Pieper CF, Snyder DC, Sloane R, et al. Leading the Way in Exercise and Diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors. Control Clin Trials. 2003;24(2):206–23.CrossRefPubMed

Lahart I, Metsios G, Nevill A, Carmichael A. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;5(54):635–54. doi:10.3109/0284186X.2014.998275.CrossRef

10.

Ballard-Barbash R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A, et al. Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst. 2009;101(9):630–43. doi:10.1093/jnci/djp068.CrossRefPubMedPubMedCentral

11.

Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28(3):753–65. doi:10.1007/s12032-010-9536-x.CrossRefPubMed

12.

Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, et al. Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat. 2011;128(1):229–36. doi:10.1007/s10549-010-1323-z.CrossRefPubMedPubMedCentral

13.

Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity levels in women attending breast screening, receiving chemotherapy and post-breast cancer treatment; a cross-sectional study. Int J Environ Res Public Health. 2014;11(5):5487–96. doi:10.3390/ijerph110505487.CrossRefPubMedPubMedCentral

14.

Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, Gilliland FD, et al. Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer. 2003;97(7):1746–57. doi:10.1002/cncr.11227.CrossRefPubMedPubMedCentral

15.

Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, et al. Physical activity levels among breast cancer survivors. Med Sci Sports Exerc. 2004;36(9):1484–91.PubMedPubMedCentral

16.

Cadmus LA, Salovey P, Yu H, Chung G, Kasl S, Irwin ML. Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials. Psycho-Oncology. 2009;18(4):343–52. doi:10.1002/pon.1525.CrossRefPubMedPubMedCentral

17.

Rogers LQ, Hopkins-Price P, Vicari S, Pamenter R, Courneya KS, Markwell S, et al. A randomized trial to increase physical activity in breast cancer survivors. Med Sci Sports Exerc. 2009;41(4):935–46. doi:10.1249/MSS.0b013e31818e0e1b.CrossRefPubMed

18.

Payne JK, Held J, Thorpe J, Shaw H. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum. 2008;35(4):635–42. doi:10.1188/08.ONF.635-642.CrossRefPubMed

19.

Daley AJ, Crank H, Saxton JM, Mutrie N, Coleman R, Roalfe A. Randomized trial of exercise therapy in women treated for breast cancer. J Clin Oncol. 2007;25(13):1713–21. doi:10.1200/JCO.2006.09.5083.CrossRefPubMed

20.

Matthews CE, Wilcox S, Hanby CL, Der Ananian C, Heiney SP, Gebretsadik T, et al. Evaluation of a 12-week home-based walking intervention for breast cancer survivors. Support Care Cancer. 2007;15(2):203–11. doi:10.1007/s00520-006-0122-x.CrossRefPubMed

21.

Herrero F, San Juan AF, Fleck SJ, Balmer J, Perez M, Canete S, et al. Combined aerobic and resistance training in breast cancer survivors: a randomized, controlled pilot trial. Int J Sports Med. 2006;27(7):573–80. doi:10.1055/s-2005-865848.CrossRefPubMed

22.

Pinto BM, Frierson GM, Rabin C, Trunzo JJ, Marcus BH. Home-based physical activity intervention for breast cancer patients. J Clin Oncol. 2005;23(15):3577–87. doi:10.1200/JCO.2005.03.080.CrossRefPubMed

23.

Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21(9):1660–8. doi:10.1200/JCO.2003.04.093.CrossRefPubMed

24.

Musanti R. A study of exercise modality and physical self-esteem in breast cancer survivors. Med Sci Sports Exerc. 2012;44(2):352–61. doi:10.1249/MSS.0b013e31822cb5f2.CrossRefPubMed

25.

Heim ME, v d Malsburg ML, Niklas A. Randomized controlled trial of a structured training program in breast cancer patients with tumor-related chronic fatigue. Onkologie. 2007;30(8–9):429–34. doi:10.1159/0000104097.PubMed

26.

Vallance JK, Courneya KS, Plotnikoff RC, Yasui Y, Mackey JR. Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J Clin Oncol. 2007;25(17):2352–9. doi:10.1200/JCO.2006.07.9988.CrossRefPubMed

27.

Baruth M, Wilcox S, Der Ananian C, Heiney S. Effects of home-based walking on quality of life and fatigue outcomes in early stage breast cancer survivors: A 12-Week pilot study. J Phys Act Health. 2013;12 Suppl 1:S110–8. doi:10.1123/jpah.2012-0339.

28.

Glasgow R, Bull S, Gillette C, Klesges L, Dzewaltowski D. Behavior change intervention research in healthcare settings: a review of recent reports with emphasis on external validity. Am J Prev Med. 2002;23(1):62–9. doi:10.1016/S0749-3797(02)00437-3.CrossRefPubMed

29.

Patsopoulos NA. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci. 2011;13(2):217–24.PubMedPubMedCentral

30.

Medicine ACoS. ACSM’s Guidelines for exercise testing and prescription. 9th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2013.

31.

Rogers LQ, Markwell S, Hopkins-Price P, Vicari S, Courneya KS, Hoelzer K, et al. Reduced barriers mediated physical activity maintenance among breast cancer survivors. J Sport Exerc Psychol. 2011;33(2):235–54.CrossRefPubMedPubMedCentral

32.

Jones LW, Courneya KS. Exercise counseling and programming preferences of cancer survivors. Cancer Pract. 2002;10(4):208–15.CrossRefPubMed

33.

Rosengren DB. Building motivational interviewing skills: a practitioner workbook. New York; London: Guilford; 2009.

34.

Miller WR, Rollnick S. Motivational interviewing: helping people change. 3rd ed. New York, NY: Guilford Press; 2013.

35.

Bull FC, Experts Working Groups. Physical Activity Guidelines in the UK: Review and Recommendations. School of Sport, Exercise and Health Sciences, Loughborough University. 2010. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213743/dh_128255.pdf. Accessed 17 Feb 2015.

36.

Demura S, Yamaji S, Goshi F, Kobayashi H, Sato S, Nagasawa Y. (2002) The validity and reliability of relative body fat estimates and the construction of new prediction equations for young Japanese adult males. J Sports Sci. 2002;20(2):153–64. doi:10.1080/026404102317200864.CrossRefPubMed

37.

Craig C, Marshall A, Sjöström M, Bauman A, Booth M, Ainsworth B, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;8(35):1381–95.CrossRef

38.

Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast (FACT-B) quality of life instrument. J Clin Oncol. 1997;15:974–86.CrossRefPubMed

39.

Radikova Z. Assessment of insulin sensitivity/resistance in epidemiological studies. Endocr Regul. 2003;37(3):189–94.PubMed

40.

Batterham A, Hopkins W. Making meaningful inferences about magnitudes. Int J Sports Physiol Perform. 2006;1(1):50–7.CrossRefPubMed

41.

Hopkins WG. Spreadsheets for analysis of controlled trials, with adjustment for a subject characteristic. Sportsci. 2006;10:46–50.

42.

Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS, et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004;57(9):898–910. doi:10.1016/j.jclinepi.2004.01.012.CrossRefPubMed

43.

Cohen J. A power primer. Psychol Bull. 1992;1(112):155–9.CrossRef

44.

Pate RR, Heath GW, Dowda M, Trost SG. Associations between physical activity and other health behaviors in a representative sample of US adolescents. Am J Public Health. 1996;86(11):1577–81.CrossRefPubMedPubMedCentral

45.

Dehghan M, Merchant AT. Is bioelectrical impedance accurate for use in large epidemiological studies? Nutr J. 2008;7:26. doi:10.1186/1475-2891-7-26.CrossRefPubMedPubMedCentral

46.

Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):3–46.CrossRefPubMed

47.

O’Keefe Jr JH, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol. 2004;43(11):2142–6. doi:10.1016/j.jacc.2004.03.046.CrossRefPubMed

48.

Edwards JE, Moore RA. Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials. BMC Fam Pract. 2003;4:18. doi:10.1186/1471-2296-4-18.CrossRefPubMedPubMedCentral

49.

Pattyn N, Cornelissen VA, Eshghi SR, Vanhees L. The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med. 2013;43(2):121–33. doi:10.1007/s40279-012-0003-z.CrossRefPubMed

50.

Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Martin BS, et al. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial. Brain Behav Immun. 2005;19(5):381–8. doi:10.1016/j.bbi.2005.04.001.CrossRefPubMed

51.

Mefferd K, Nichols JF, Pakiz B, Rock CL. A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors. Breast Cancer Res Treat. 2007;104(2):145–52. doi:10.1007/s10549-006-9410-x.CrossRefPubMed

52.

Nuri R, Kordi MR, Moghaddasi M, Rahnama N, Damirchi A, Rahmani-Nia F, et al. Effect of combination exercise training on metabolic syndrome parameters in postmenopausal women with breast cancer. J Cancer Res Ther. 2012;8(2):238–42. doi:10.4103/0973-1482.98977.CrossRefPubMed

53.

Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale exercise and survivorship study. Cancer Epidemiol Biomark Prev. 2009;18(1):306–13.CrossRef

54.

Schmitz KH, Ahmed RL, Hannan PJ, Yee D. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomark Prev. 2005;14(7):1672–80. doi:10.1158/1055-9965.EPI-04-0736.CrossRef

55.

Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomark Prev. 2003;12(8):721–7.

56.

Ross SA, Gulve EA, Wang M. Chemistry and biochemistry of type 2 diabetes. Chem Rev. 2004;104(3):1255–82.CrossRefPubMed

57.

Watkinson C, van Sluijs EM, Sutton S, Hardeman W, Corder K, Griffin SJ. Overestimation of physical activity level is associated with lower BMI: a cross-sectional analysis. Int J Behav Nutr Phys Act. 2010;7:68. doi:10.1186/1479-5868-7-68.CrossRefPubMedPubMedCentral

Title: Randomised controlled trial of a home-based physical activity intervention in breast cancer survivors
Authors: Ian M. Lahart
George S. Metsios
Alan M. Nevill
George D. Kitas
Amtul R. Carmichael
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-016-2258-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

ClinicalTrials.gov identifier

Please log in to get access to this content

Other articles of this Issue 1/2016

Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design

Tumor slice culture system to assess drug response of primary breast cancer

Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab

Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems

Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study

After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer